Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway

<div>JP suppresses IRAK1 activation in LPS-stimulated peritoneal macrophages of MRL/lpr lupus mice. Cells were treated with LPS either alone or with JP (2.5%) for 24 h later, the cells were subjected by immunofluorescent assays using DAPI (blue) and FITC (green). Data are representative images (magnification, 40× for immunofluorescent staining) of individual groups from three separate experiments. A control group; B LPS group; C LPS plus JP group.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway 

Figure 2 | Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway 